Fertility and Sterility
Volume 93, Issue 3 , Pages 691-696 , February 2010

Cancer and fecundity issues mandate a multidisciplinary approach

  • Dominique de Ziegler, M.D.

      Affiliations

    • Université Paris Descartes, Service de Gynécologie Obstétrique II et Médecine de la Reproduction, Paris, France
    • Corresponding Author InformationReprint requests: D. de Ziegler, M.D., Service de Gynécologie Obstétrique II, Hôpital St. Vincent de Paul, 82 Bd Denfert-Rocherau, 75014 Paris, France (FAX: 33-1 58 41 1870).
    • ,
  • Isabelle Streuli, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Hospital of Morges, Morges, Switzerland
    • ,
  • Ioannis Vasilopoulos, M.D.

      Affiliations

    • Université Paris Descartes, Service de Gynécologie Obstétrique II et Médecine de la Reproduction, Paris, France
    • ,
  • Christine Decanter, M.D.

      Affiliations

    • Department of Endocrine Gynecology and Reproductive Medicine, Hôpital Jeanne de Flandre, Centre Hospitalier Régional Universitaire (CHRU), Lille, France
    • ,
  • Pascale This, M.D.

      Affiliations

    • Institut Curie, Paris, France
    • ,
  • Charles Chapron, M.D.

      Affiliations

    • Université Paris Descartes, Service de Gynécologie Obstétrique II et Médecine de la Reproduction, Paris, France

Received 30 October 2008 ,Revised 8 December 2008 ,Accepted 11 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 D.deZ. holds stock in Ultrst, LLC. I.S. has nothing to disclose. I.V. has nothing to disclose. C.D. has nothing to disclose. P.T. has received grants from Pfizer and Novartis. C.C. has nothing to disclose.

PII: S0015-0282(08)04726-2

doi: 10.1016/j.fertnstert.2008.12.028

Fertility and Sterility
Volume 93, Issue 3 , Pages 691-696 , February 2010

Article Tools

* Image Usage & Resolution